American Academy of Dermatology Meeting

American Academy of Dermatology Meeting

April 24, 2021
1 min watch
Save

VIDEO: Roflumilast foam well tolerated, effective in patients with scalp psoriasis

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this video from AAD VMX 2021, Kim A. Papp, MD, discusses a recent study investigating safety and efficacy of once-daily roflumilast foam 0.3% in patients with scalp and body psoriasis.